Designed to run quickly without causing lag
Now came the hard part. Elena recruited 200 volunteers in a region with active Phoenix transmission. Half got AVI-7, half got placebo, double-blinded (neither patient nor doctor knew who got what). After 14 days, 18 people on placebo had confirmed Phoenix infections. In the AVI-7 group: just 3 infections, all mild. The drug showed 83 percent protection. But the real test was yet to come.
